http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2009006528-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c76ecadad74a1a35270b3e3a34d60f37
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
filingDate 2007-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96f2e340fddf7ffdfcfd8863a54dd4ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_615717ca261a3573bc70783c725c5e92
publicationDate 2009-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2009006528-A
titleOfInvention SUCCINATE SALT OF LA 2 - ((4- (1-METHYL-4- (PIRIDIN-4-IL) -1H-PIRAZOL- 3-IL) PHENOXY) METHYL) QUINOLINE.
abstract The present invention relates to a succinate salt of 2- ((4- (1-methyl-4- (pyridin-4-yl) -1 H-pyrazol-3-yl) phenoxy) methyl) quoline, and a method for treating disorders of the Central Nervous System (CNS) and other disorders in a mammal, which includes a human being, by administering to the mammal the succinate salt. "Also" refers to pharmaceutical compositions containing a pharmaceutically acceptable carrier and succinate salt.
priorityDate 2006-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11581936
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419476153

Total number of triples: 30.